Keep up to date with Drugs & Crime

Latest on European drug markets

New online resource from European Centre for Monitoring Drugs and Drug Abuse provides excellent concise overview of €24billion European drug markets.

Share This Post

Share on twitter
Share on facebook
Share on linkedin
Share on email

Comprehensive overview

Earlier this month (11 January 2017) the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) published an online poster summarising  the second comprehensive overview of illicit drug markets in the European Union undertaken in partnership with Europol.

The report considers the impacts of the drug market on wider society and reviews the markets for cannabis, heroin, cocaine, amphetamine, methamphetamine, MDMA and new psychoactive substances. It also provides concrete action points to inform policy development at EU and national level.

This post reproduces some of the key images from this poster to give readers a quick primer in the latest developments in the €24billion European drug market.

Ramifications

Drug markets have wide-ranging and varied impacts; linking to wider criminality and having negative effects on the licit economy, government institutions and society more generally. Drugs are big business: key concerns for most participants are maximising profits, ensuring sustainability and maintaining competitive advantage, while minimising risk.

Understanding how they operate can identify opportunities to intervene and damage their operations. Key influences on new developments in the markets and how the criminals involved operate are:

  1. Globalisation — this simultaneously facilitates drug supply, by generally improving its efficiency and multiplying opportunities for trafficking, while hampering drug supply reduction activities
  2. Technological developments and the Internet — these not only provide new ways to access customers and suppliers but also opportunities to enhance the efficiency and security of off-line criminal activities

Cannabis, Cocaine, Heroin, (Meth)Amphetamine & MDMA

The report provides detailed information on the different markets relating to different substances. As you can see the markets in cannabis, heroin and cocaine comprise 90% of the total market:

New Psychoactive Substances

The report highlights a number of  key issues including:

  • The continuing increased in popularity and availability of NPS and development of new substances
  • Production and distribution is globalised
  • The key role of the internet
  • Sophisticated marketing strategies
  • Significant health risks of using NPS

The graphic below shows the number of different NPS reported to the EU warning system for the first time:

Conclusion

All drug markets are in a constant state of evolution and modification, responding to (and stimulating) demands for new substances and seeking to avoid law enforcement efforts. The pace of change has unsurprisingly accelerated since the rise of the internet and the EMCDDA/Europol poster provides an invaluable snapshot of the current state of play, as we understand it.

Share This Post

Share on twitter
Share on facebook
Share on linkedin
Share on email

Related posts

Prison healthcare
Alcohol & Drugs
Prison and drugs in Europe

EMCDDA report on latest developments in the field of drug use and prison. How does the UK compare with other countries?

Alcohol & Drugs
The latest (2021) drug trends

The European Monitoring Centre for Drugs and Drug Addiction has published its 2021 drug report with the latest trends and developments.

Alcohol & Drugs
Drugs even more available across Europe

EMCDDA annual report highlights fears about innovative drug distribution models developed during lockdown and the impact of COVID-19.

Leave a Reply

Your email address will not be published.

keep informed

One email every day at noon